Filtered by speaker:Dan Rasmussen×
Searching...
2 results for “pharma research” by Dan Rasmussen
...Pharma's acquisitions that were coming from China were single digits. And I think in '25, it was between 3040% of their acquisitions. So this is a sea change in Big Pharma's sourcing strategy. And, you know, they have oriented more towards these Chin
20:22 / 21:27
from transcript20:22 – 21:27
...pharma is increasingly buying their new early stage assets out of China. And so, you know, go back five, six years. The percentage of Big Pharma's acquisitions that were coming from China were single digits.
19:33 / 20:37
from transcript19:33 – 20:37
Have a podcast?
Run your podcast through Clypt
Get ranked clips, hooks, and ready-to-post copy from your own episodes. Free to try.